Physician

David R. Bryson, M.D.

According to 2025 Medicare claims, David Bryson, M.D. (NPI: 1346248077) practices hematology/oncology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is BRYSON CANCER CARE INC (NPI: 1508883257; TIN: 20-1673427) and primary practice location at 93291-5143.

Bryson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 341 traditional Medicare patients, billed 264,376 HCPCS/CPT codes, and received $3,914,075 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,580 prescription claims across 245 beneficiaries totaling $3,733,044 in drug costs, led by Revlimid (Lenalidomide). DME data shows 96 claims. Open Payments data shows 311 records totaling $7,122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,877,241 and ending at $3,914,075. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $856,156 to $3,733,044. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,984 to $11,390.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	505	317,518	$2,877,241
2016	509	388,349	$3,877,438
2017	464	323,986	$3,271,512
2018	452	353,246	$3,204,133
2019	426	338,190	$3,378,125
2020	378	303,739	$3,004,747
2021	350	177,449	$2,046,466
2022	319	231,861	$2,583,162
2023	323	240,665	$3,263,530
2024	341	264,376	$3,914,075

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	2,245	$856,156
2016	258	2,619	$1,494,021
2017	258	2,383	$1,121,634
2018	227	2,353	$1,400,316
2019	239	2,481	$1,978,810
2020	234	2,511	$3,807,801
2021	220	2,176	$3,008,671
2022	207	2,357	$3,230,770
2023	227	2,366	$3,228,097
2024	245	2,580	$3,733,044

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	407	$50,215
2016	12	224	$10,466
2017	N/R	249	$19,331
2018	N/R	291	$20,238
2019	12	303	$20,200
2020	12	267	$14,353
2021	N/R	135	$6,755
2022	11	201	$9,239
2023	12	179	$17,191
2024	11	96	$10,109

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	295	749	$102
96375	Injection of additional new drug or substance into vein	60	361	$13
96372	Injection of drug or substance under skin or into muscle	80	592	$12
36415	Insertion of needle into vein for collection of blood sample	270	1,042	$9
J7050	Infusion, normal saline solution, 250 cc	60	504	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	30	833	$502,519
Lenalidomide	Lenalidomide	25	581	$333,646
Xtandi	Enzalutamide	21	610	$272,963
Kisqali	Ribociclib Succinate	16	448	$261,639
Orserdu	Elacestrant Hcl	11	330	$246,523

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0680	Non-pneumatic compression controller with sequential calibrated gradient pressure	Y	N/R	11	$4,821
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	11	14	$2,371
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	33	$2,098
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	27	$418
E0682	Non-pneumatic sequential compression garment, full arm	Y	N/R	11	$402

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	311	$7,122	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David R. Bryson, M.D.?

Tedicare shows public-source Medicare data for David R. Bryson, M.D. (NPI 1346248077), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David R. Bryson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David R. Bryson, M.D.?

David R. Bryson, M.D. is linked to BRYSON CANCER CARE INC (billing NPI 1508883257) in the available physician profile data.

Does David R. Bryson, M.D. have Open Payments data?

David R. Bryson, M.D. has 311 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.